Treatment of Acute SIV infection in cynomolgus Monkeys with 2′,3′-dideoxyinosine (ddl) and 2′,3′-dideoxythymidiene (d4T)
- 1 December 1991
- journal article
- Published by SAGE Publications in Antiviral Chemistry and Chemotherapy
- Vol. 2 (6) , 357-361
- https://doi.org/10.1177/095632029100200604
Abstract
2′,3′-dideoxyinosine (ddl) and 2′,3′-dideoxythymidiene (d4T) have been reported to inhibit the multiplication of human immunodeficiency virus (HIV) in patients, ddl and d4T were administered subcutaneously to cynomolgus monkeys starting 8 h prior to inoculation with 10–50 infectious doses of simian immunodeficiency virus (SIVSM). ddl, at a daily dose of 3 × 3.6 mg kg−1 for 10 days significantly delayed the appearance of SIVSM p24/26 antigen. A significant delay in the appearance of SIVSM p24/26 antigen was also seen when using a daily dose of 3 × 1 mg kg −1 of d4T for 10 days. Neither ddl nor d4T prevented SIVSM infection despite administration prior to virus inoculation.Keywords
This publication has 28 references indexed in Scilit:
- Pharmacokinetics of 2',3'-dideoxyinosine in monkeysAntimicrobial Agents and Chemotherapy, 1991
- Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- Nonhuman Primate Models for Evaluation of AIDS TherapyAnnals of the New York Academy of Sciences, 1990
- Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complexThe Lancet, 1990
- In vitro screening for antiretroviral agents against simian immunodeficiency virus (SIV)Antiviral Research, 1990
- Once-Daily Administration of 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related ComplexNew England Journal of Medicine, 1990
- 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related ComplexNew England Journal of Medicine, 1990
- Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assayAntimicrobial Agents and Chemotherapy, 1990
- Spectrum of disease in macaque monkeys chronically infected with SIV/SMMVeterinary Immunology and Immunopathology, 1989
- 1-(2,3-Dideoxy-.beta.-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agentJournal of Medicinal Chemistry, 1989